Mimedx (MDXG) Accounts Payables (2010 - 2026)

Mimedx (MDXG) has 17 years of Accounts Payables data on file, last reported at $11.5 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 29.27% year-over-year to $11.5 million; the trailing twelve-month figure through Mar 2026 stood at $11.5 million (up 29.27% YoY), and the FY2025 full-year result was $14.5 million, up 96.09% from the prior year.
• Accounts Payables slipped to $11.5 million in Q1 2026, from $14.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $14.5 million in Q4 2025 to a low of $6.9 million in Q3 2024.
• A 5-year average of $9.1 million and a median of $8.5 million in 2025 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables fell 24.49% in 2024 and surged 96.09% in 2025, its largest moves.
• Tracing MDXG's Accounts Payables over 5 years: stood at $8.5 million in 2022, then advanced by 7.03% to $9.0 million in 2023, then declined by 18.11% to $7.4 million in 2024, then surged by 96.09% to $14.5 million in 2025, then retreated by 21.09% to $11.5 million in 2026.
• Business Quant data shows MDXG's Accounts Payables at $11.5 million in Q1 2026, $14.5 million in Q4 2025, and $11.4 million in Q3 2025.